- Home
- CDTX vs CYRX Comparison
CDTX vs CYRX Comparison
Compare CDTX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- CYRX
- Stock Information
- Founded
- CDTX 2012
- CYRX 1999
- Country
- CDTX United States
- CYRX United States
- Employees
- CDTX N/A
- CYRX N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- CDTX Health Care
- CYRX Health Care
- Exchange
- CDTX Nasdaq
- CYRX Nasdaq
- Market Cap
- CDTX 259.0M
- CYRX 277.5M
- IPO Year
- CDTX 2015
- CYRX N/A
- Fundamental
- Price
- CDTX $21.69
- CYRX $5.86
- Analyst Decision
- CDTX Strong Buy
- CYRX Strong Buy
- Analyst Count
- CDTX 8
- CYRX 7
- Target Price
- CDTX $38.00
- CYRX $11.29
- AVG Volume (30 Days)
- CDTX 164.0K
- CYRX 465.7K
- Earning Date
- CDTX 05-08-2025
- CYRX 05-07-2025
- Dividend Yield
- CDTX N/A
- CYRX N/A
- EPS Growth
- CDTX N/A
- CYRX N/A
- EPS
- CDTX N/A
- CYRX N/A
- Revenue
- CDTX $1,275,000.00
- CYRX $228,385,000.00
- Revenue This Year
- CDTX N/A
- CYRX N/A
- Revenue Next Year
- CDTX N/A
- CYRX $8.19
- P/E Ratio
- CDTX N/A
- CYRX N/A
- Revenue Growth
- CDTX N/A
- CYRX N/A
- 52 Week Low
- CDTX $10.14
- CYRX $4.58
- 52 Week High
- CDTX $28.42
- CYRX $17.41
- Technical
- Relative Strength Index (RSI)
- CDTX 56.70
- CYRX 52.28
- Support Level
- CDTX $19.97
- CYRX $5.34
- Resistance Level
- CDTX $22.80
- CYRX $5.89
- Average True Range (ATR)
- CDTX 1.37
- CYRX 0.42
- MACD
- CDTX 0.29
- CYRX 0.04
- Stochastic Oscillator
- CDTX 74.55
- CYRX 77.38
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.